PillRx only · Injection, Solution · Subcutaneous
Mepolizumab
Brands: Nucala · Mepolizumab
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
16K
Rx · 2026 Q1
18K
Units dispensed
+20%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| GlaxoSmithKline LLC | unknown | 5 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 6, 2019RECALLRecall (Class II): Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactu…
Temperature Abuse; Product stored and shipped outside of labeled storage requirements. — Recalling firm: Cardinal Health dba Specialty Pharmaceutical Services — Nationwide in the U.S.